CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
islet transplantationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01123187
NCT01123187N/ACompleted
CompareCT.gov

Phase 2 Study of Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation With Steroid Free Immunosuppression

University Hospital, Lille·interventional·Posted May 14, 2010·Updated Nov 28, 2025

In Brief

A clinical study evaluating islet transplantation for Type 1 Diabetes and 2 related conditions. Completed, enrolled 14 participants across 1 site.

Detailed Summary

This single center phase 2 clinical trial, is designed for confirming the efficacy and safety of sequential islet allotransplantation with steroid free immunosuppression in patients with previous kidney transplantation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes, Organ Transplantation, Immunosuppression
CountriesFrance
CollaboratorsInstitut National de la Santé Et de la Recherche Médicale, France

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 14, 2010
Enrollment StartMar 1, 2003
Primary CompletionMar 1, 2014
Study CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 yearsPosted 16.1 years ago

Interventions

islet transplantationprocedure

Islet transplantation consisted of up to three sequential fresh islet infusions within three months. Access to the portal vein was gained under general anesthesia by percutaneous catheterisation of a peripheral portal branch under ultrasound guidance or by surgical catheterisation of a small mesenteric vein.